Investors

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds

Webcast ImageWebcast
Q1 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call (Replay)
05/04/15 at 4:30 p.m. ET
Q1 2015 AcelRx Pharmaceuticals, Inc. Earnings Conference Call
Monday, May 4, 2015 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
AcelRx Pharmaceuticals, Inc. at the Bank of America 2015 Health Care Conference (Live)
05/12/15 at 12:00 p.m. PT
AcelRx Pharmaceuticals, Inc. at the Bank of America 2015 Health Care Conference
Tuesday, May 12, 2015 12:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
PDF File ACRX Corporate Presentation - 2/24/15
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. AcelRx has announced positive results from each of the three Phase 3 clinical trials for Zalviso and has submitted an NDA to the FDA seeking its approval. AcelRx also announced positive top-line results for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from U.S. Army Medical Research and Materiel Command. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.
ACRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$3.04
Change (%) Stock is Down 1.17 (27.62%)
Volume2,892,659
Data as of 05/05/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

    More >>
05/04/15AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results
REDWOOD CITY, Calif., May 4, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided a regulatory update on Zalviso and reported financial results for the three months ended March 31, 2015. Zalviso Regulatory Update On April 21, 2015, AcelRx submitted a request to the Division of Anesthesia, Analgesia, and Add... 
Printer Friendly Version
05/01/15AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May
REDWOOD CITY, Calif., May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Timothy E. Morris, chief financial officer  will be participating in three upcoming investor events.  Details of the events are as follows: Mizuho Third Annual Healthcare Corporate Access Day Date: Tuesday, May 5 Location:  The Omni Ber... 
Printer Friendly Version
04/30/15AcelRx Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 4th, 2015
REDWOOD CITY, Calif., April 30, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it will release First Quarter financial results after market close on Monday, May 4th, 2015. AcelRx management will host an investment-community conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on May 4th,... 
Printer Friendly Version

Upcoming Events

    More >>
DateTitle
05/12/15 12:00 p.m. PT
AcelRx Pharmaceuticals, Inc. at the Bank of America 2015 Health Care Conference
LocationEncore at the Wynn
Las Vegas, NV
05/18/15
AcelRx Pharmaceuticals, Inc. at the UBS Global Healthcare Conference
LocationSheraton New York Times Square Hotel
New York, NY

Receive E-mail Alerts 

Sign up to receive e-mail alerts whenever AcelRx Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

AcelRX

CONTACT